期刊文献+

隆突性皮肤纤维肉瘤临床病理学分析

Clinical and pathological analysis of dermatofibrosarcoma protuberans
下载PDF
导出
摘要 目的:探讨隆突性皮肤纤维肉瘤(DFSP)的临床病理特征、诊断及鉴别诊断要点。方法:回顾性分析2017年-2020年诊断的12例DFSP患者的临床表现、组织病理学特征、免疫组化特点及治疗、预后。结果:12例DFSP患者中,男性9例,女性3例,腹部7例、头颈部2例、肩部1例、臀部1例,上肢1例。肿瘤组织在真皮层及皮下呈浸润性生长并形成车辐状或席纹状结构,免疫组化检测CD34、Vimentin弥漫阳性,S-100均阴性。1例FS-DFSP CD34在FS区域表达减弱,Ki-67指数较高。结论:通过组织病理学、免疫组化检测可以确诊DFSP,规范性手术切除是主要的治疗方式。 Objective:To investigate the clinicopathological features,diagnosis and differential diagnosis of fibrosarcoma protuberans.Methods:The clinical manifestations,histopathological features,immunohistochemical features,treatment and prognosis of 12 DFSP diagnosed from 2017 to 2020 were retrospectively analyzed.Results:Among the 12 cases of DFSP,there were 9 males and 3 females.There were 7 cases of abdomen,2 cases of head and neck,1 case of shoulder,1 case of buttocks,and 1 case of upper limb.The tumor tissue is infiltrating in the dermis and subcutaneously and forms"storiform"structure,Immunohistochemical CD34,Vimentin diffuse positive,S-100 negative.One case FS-DFSP CD34 decreased expression in the FS region and a higher Ki-67 index.Conclusion:DFSP can be confirmed by histopathology and immunohistochemistry,standard surgical resection is the main treatment.
作者 胡小伟 胡万生 HU Xiao-wei;HU Wan-sheng(The People's Hospital of Zongyang County,Zongyang 246700,Anhui)
出处 《安徽卫生职业技术学院学报》 2021年第1期99-101,共3页 Journal of Anhui Health Vocational & Technical College
关键词 皮肤纤维肉瘤 隆突性 病理特征 鉴别诊断 dermatofibrosarcoma protuberans pathological features differential diagnosis
  • 相关文献

参考文献5

二级参考文献29

  • 1Dimitropoulos VA. Dennatotlbrosarcoma protuberans. Dermalol Ther, 2008, 21(6) : 428-432.
  • 2Bowne WB, Antonescu CR, Leung DH, et Dermatofibrosarcoma protuberans: a clinicopathologie analysis patients treated and followed at a single institution. Cancer, 200 88(12) :2711-2720. |.
  • 3Fiore M, Miceli R, Mussi C, et al. Dermatoflbrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate. J Clin Oncol, 2005,23(30) : 7669-7675.
  • 4Mentzel T, Beham A, Kalenkamp D, et al. Fibrosarcomatous clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance. Am J Surg PatAol, 1998, 22(5) :576-587.
  • 5Voth H, Landsberg J, Hinz T, et al. Management of dermatofibrosarcoma protuberans with fibnmarcomateus transformation: an evidence-based review of the literature. J Eur Acad Dermatol Venereol, 2011,25(12) :1385-1391.
  • 6Aiba S, Tabata N, Ishii H, et al. Dermatofibrosarcoma protuberans is a unique fibrohistioeytic tumour expressing CD34. BrJ l)ennatol, 1992, 127(2) :79-84.
  • 7Kutzner H. Expression of the human progenitor cell antigen CD34 (HPCA-I) distinguishes dermatoflbrosaveoma protuberans from fibrous histiocytoma in fonnalin-fLxed, paraffln-embedded tissue. J Am Acad Dermatol, 1993, 28(4) :613-617.
  • 8Weiss SW, Goldblum JR. Enzinger Weiss's soft tissue tumor. 5th ed. St Louis: Mosby Elsevier, 2008.
  • 9Penner DW. Metastasizlng dermatofibrosarcoma protuberans: a case report. Cancer, 1951,4(5) :1083-1086.
  • 10Kim MS, Kim KS, Han HY, et al. Fibrosarcomatous transformation in dermatofibrosarcoma protuberarm of the breast--a case report. J Clin Ultrasound, 2009, 37(7) :420-423.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部